[1] United States Government. Food & Drug Administration (FDA). Fatalities reported to FDA following blood collection and transfusion: annual summary for FY2017[EB/OL].(2021-08-02).https://www.fda.gov/media/124796/download.
[2] LAFEUILLADE B,EB F,OUNNOUGHENE N,et al.Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008[J]. Transfusion,2015,55(3):636-646.
[3] EDER A F,KENNEDY J M,DY B A,et al.Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions:the American Red Cross experience (2004-2006)[J]. Transfusion,2007,47(7):1134-1142.
[4] HERMAN J H,KLUMPP T R.Single-donor platelets reduce the risk of septic platelet transfusion reactions[J]. Transfusion,2002,42(4):506-507.
[5] BENJAMIN R J,KLINE L,DY B A,et al.Bacterial contamination of whole-blood-derived platelets:the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross[J]. Transfusion,2008,48(11):2348-2355.
[6] SATAKE M,KOZAKAI M,MATSUMOTO M,et al.Platelet safety strategies in Japan:impact of short shelf life on the incidence of septic reactions[J]. Transfusion,2020,60(4):731-738.
[7] 朱立苇,孟忠华,倪波,等.献血者穿刺部位皮肤消毒方法的效果评价[J].中华医院感染学杂志,2013,23(20):4992-4993.
[8] KUNDRAPU S,SRIVASTAVA S,GOOD C E,et al.Bacterial contamination and septic transfusion reaction rates associated with platelet components before and after introduction of primary culture:experience at a US Academic Medical Center 1991 through 2017[J].Transfusion,2020,60(5):974-985.
[9] 中华人民共和国卫生部.消毒技术规范[S].北京:中华人民共和国卫生部,2002:174.
[10] WAGNER S J,FRIEDMAN L I,DODD R Y.Transfusion-associated bacterial Sepsis[J].Clin Microbiol Rev,1994,7(3):290-302.
[11] WAGNER S J,ROBINETTE D,FRIEDMAN L I,et al.Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria:anin vitro model[J]. Transfusion,2000,40(3):335-338.
[12] OLTHUIS H,PUYLAERT C,VERHAGEN C,et al.A simple method to remove contaminating bacteria during venepuncture(abstract)[J].Vox Sang,1996,70(Suppl 2):113.
[13] BRUNEAU C,PEREZ P,CHASSAIGNE M,et al.Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations[J]. Transfusion,2001,41(1):74-81.
[14] SATAKE M,MITANI T,OIKAWA S,et al.Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan[J]. Transfusion,2009,49(10):2152-2157.
[15] MCDONALD C P,ROY A,MAHAJAN P,et al.Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion[J]. Vox Sang,2004,86(3):178-182.
[16] WALTHER-WENKE G,DÄUBENER W,HEIDEN M,et al. Effect of safety measures on bacterial contamination rates of blood components in Germany[J]. Transfus Med Hemother,2011,38(4):231-235.
[17] 姚根宏. 输血相关细菌污染研究进展[J]. 中国血液流变学杂志,2010,20(3):506-508.
[18] BUCHHOLZ D H,AUBUCHON J P,SNYDER E L,et al.Effects of white cell reduction on the resistance of blood components to bacterial multiplication[J]. Transfusion,1994,34(10):852-857.
[19] DUMONT L J,WOOD T A,HOUSMAN M,et al.Bacterial growth kinetics in ACD-A apheresis platelets:comparison of plasma and PAS Ⅲ storage[J]. Transfusion,2011,51(5):1079-1085.
[20] PICKER S M,TAUSZIG M E,GATHOF B S.Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution[J]. Transfusion,2012,52(3):510-516.
[21] KAUFMAN R M.Uncommon cold:could 4 degrees C storage improve platelet function?[J]. Transfusion,2005,45(9):1407-1412.
[22] 刘磊. 血小板保存技术的应用研究进展[J]. 解放军医药杂志,2020,32(8):108-111.
[23] PRAX M,BEKEREDJIAN-DING I,KRUT O.Microbiological screening of platelet concentrates in Europe[J]. Transfus Med Hemother,2019,46(2):76-86.
[24] Brailsford S R,TossellJ,MorrisonR,et al. Failure of bacterial screening to detect Staphylococcus aureus:the English experience of donor follow-up[J]. Vox Sang,2018:2018 May 24.
[25] ABELA M A,FENNING S,MAGUIRE K A,et al.Bacterial contamination of platelet components not detected by BacT/ALERT ®[J]. Transfus Med,2018,28(1):65-70.
[26] JUTZI M,MANSOURI TALEGHANI B,RUEESCH M,et al.Nationwide implementation of pathogen inactivation for all platelet concentrates in Switzerland[J]. Transfus Med Hemother,2018,45(3):151-156.
[27] CAZENAVE J P,ISOLA H,WALLER C,et al.Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center:impact on patient outcomes and component utilization during a 3-year period[J]. Transfusion,2011,51(3):622-629.
[28] BENJAMIN R J,BRASCHLER T,WEINGAND T,et al.Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems[J]. Transfusion,2017,57(12):2946-2957.
[29] LI J,DE KORTE D,WOOLUM M D,et al.Pathogen reduction of buffy coat platelet concentrates using riboflavin and light:comparisons with pathogen-reduction technology-treated apheresis platelet products[J]. Vox Sang,2004,87(2):82-90.
[30] RUANE P H,EDRICH R,GAMPP D,et al.Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light[J]. Transfusion,2004,44(6):877-885.
[31] JUTZI M,MANSOURI TALEGHANI B,RUEESCH M,et al.Nationwide implementation of pathogen inactivation for all platelet concentrates in Switzerland[J]. Transfus Med Hemother,2018,45(3):151-156.
[32] IRSCH J,LIN L.Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system™[J]. Transfus Med Hemother,2011,38(1):19-31.
[33] YPMA P F,VAN DER MEER P F,HEDDLE N M,et al. A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products:the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial[J]. BMJ Open,2016,6(1):e010156.
[34] AABB.Recommendations to address residual risk of bacterial contamination of platelets[EB/OL].(2021-06-08).https://www.aabb.org/docs/default-source/default-document-library/resources/association-bulletins/ab12-04.pdf?sfvrsn=145136c3_0.
[35] MCDONALD C,ALLEN J,BRAILSFORD S,et al.Bacterial screening of platelet components by National Health Service Blood and Transplant,an effective risk reduction measure[J]. Transfusion,2017,57(5):1122-1131.
[36] PUCKETT A,DAVISON G,ENTWISTLE C C,et al.Post transfusion septicaemia 1980-1989:importance of donor arm cleansing[J]. J Clin Pathol,1992,45(2):155-157.
[37] 朱立苇,徐健,黄伯里. 血小板成分细菌污染和预防[J]. 国际输血及血液学杂志,2006(3):270-272.
[38] MURPHY W G,FOLEY M,DOHERTY C,et al.Screening platelet concentrates for bacterial contamination:low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety[J]. Vox Sang,2008,95(1):13-19.
[39] RAMIREZ-ARCOS S,DIFRANCO C,MCINTYRE T,et al.Residual risk of bacterial contamination of platelets:six years of experience with sterility testing[J]. Transfusion,2017,57(9):2174-2181.
[40] BENJAMIN R J,WAGNER S J.The residual risk of Sepsis:modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates[J]. Transfusion,2007,47(8):1381-1389.
[41] 张燕,方建华,金新莉,等. 无偿献血者单采血小板细菌检测结果分析[J]. 临床血液学杂志,2019,32(6):450-452.
[42] 何华庆,韩玲,涂娟,等. 1086例单采血小板细菌培养结果分析[J]. 实验与检验医学,2015,33(5):688-689.
[43] 林栋,崔四平,苏婉兰,等. 两种血小板制品细菌培养结果分析[J]. 中国医药科学,2014,4(11):119-121.
[44] 徐忠,邱颖婕,陈琦,等. 14923例单采血小板细菌检测结果分析[J]. 中国输血杂志,2016,29(9):974-976.
[45] 朱立苇,徐健. 厌氧培养在单采血小板细菌筛查中的作用[J]. 中国输血杂志,2017,30(7):826-828.
[46] VOLLMER T,DABISCH-RUTHE M,WEINSTOCK M,et al.Late sampling for automated culture to extend the platelet shelf life to 5 days in Germany[J]. Transfusion,2018,58(7):1654-1664.
[47] BRECHER M E,HAY S N,ROSE A D,et al.Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit[J]. Transfusion,2005,45(9):1512-1517.
[48] BRUHN R,CUSTER B,VANDERPOOL S,et al.Impact of increasing sample volume from 4 ml to 8 ml on bacterial detection rates in apheresis platelets:a meta-analysis[J]. Vox Sang,2015,108(3):318-320.
[49] KAMEL H,TOWNSEND M,BRAVO M,et al.Improved yield of minimal proportional sample volume platelet bacterial culture[J]. Transfusion,2017,57(10):2413-2419.
[50] TOMASULO P A,WAGNER S J.Predicting improvement in detection of bacteria in apheresis platelets by maintaining constant component sampling proportion[J]. Transfusion,2013,53(4):835-842.
[51] WHITE S K,SCHMIDT R L,WALKER B S,et al.Bacterial contamination rate of platelet components by primary culture:a systematic review and meta-analysis[J]. Transfusion,2020,60(5):986-996.
[52] PALAVECINO E L,YOMTOVIAN R A,JACOBS M R.Bacterial contamination of platelets[J]. TransfusApher Sci,2010,42(1):71-82.
[53] 王庆,王德文,梁兵,等. 东莞市17762例无偿献血者血小板细菌培养结果分析[J]. 广东医学院学报,2014,32(3):314-316.
[54] THYER J,PERKOWSKA-GUSE Z,ISMAY S L,et al.Bacterial testing of platelets - has it prevented transfusion-transmitted bacterial infections in Australia?[J]. Vox Sang,2018,113(1):13-20.
[55] 刘宇宁,王迅,费丹娜,等. 核酸扩增法检测细菌的方法研究及其在浓缩血小板制品细菌检测中的初步应用[J]. 中国输血杂志,2017,30(7):702-704.
[56] 王少礼,高瞻,黄梅,等. 基于高通量测序和培养组学的血小板中细菌检测方法的建立[J]. 中国输血杂志,2020,33(4):321-327. |
